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1. Introduction 
Increases in platelet CAMP inhibit platelet function 
[ 11, an effect that is associated with the phosphory- 
lation ofMr 22 000 and 24 000 membrane polypep- 
tides in intact platelets [2,3]. The presence of both 
soluble [4-71 and membrane-bound [8] CAMP-depen- 
dent protein kinases has been reported in platelets. In 
one study, addition of soluble protein kinase with the 
ion-exchange characteristics of the type 1 enzyme was 
required for the CAMP-dependent phosphorylation of 
the Mr 22 000 membrane polypeptide [7], but pre- 
liminary experiments in this laboratory have indicated 
that a membrane-bound CAMP-dependent protein 
kinase can phosphorylate this polypeptide [3]. We 
have, therefore, investigated the distribution of CAMP- 
dependent protein kinase activity and of photoaffinity- 
labelled CAMP-binding proteins between the particu- 
late and supernatant fractions of platelets sonicated 
under various conditions. The results showed that 
provided proteolysis was prevented, the particulate 
fraction contained about 20% of the total platelet 
CAMP-dependent protein kinase activity and about 
6% of the type I CAMP-binding regulatory subunits 
(RI), whereas almost all the type II regulatory sub- 
units (Rll) were found in the supernatant. 
2. Materials and methods 
Histone (Type IIA), nucleotides, EGTA, DFP, 
leupeptin, aprotinin and benzamidine were obtained 
from Sigma Chemical Co., [y-32P]ATP from Amersham 
Abbreviations: CAMP, cyclic AMP; SDS, sodium dodecyl- 
sulphate; EGTA, ethyleneglycol-his@-aminoethyl ether)- 
N,N’-tetraacetate; DFP, diisopropylfluorophosphate 
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Corporation and 8-azido- [““PI CAMP from ICN. 
Human platelets, washed as described elsewhere 
191, were finally resuspended in Tyrode’s solution 
without albumin at a concentration of 5 X 10’ ml-‘. 
Samples of platelet suspension (3-5 ml) were mixed 
with the indicated additions, cooled to 0°C and lysed 
by sonication for 4 X 15 s [2]. Soluble and particulate 
fractions were isolated by centrifugation at 90 000 X g 
for 60 min at 4°C. The latter were resuspended in 
Tyrode’s solution containing the same additions. 
Rabbit skeletal and bovine heart muscle were 
homogenized in a Waring blender for 2 min at 0°C in 
3 vol. of 4 mM EDTA, pH 7.0, containing 2 mM di- 
thiothreitol. These homogenates were centrifuged at 
25 000 X g for 30 min at 4°C to give supernatants 
that were stored at -50°C until photoaffinity labelled 
(see below). 
Protein kinase assays (final vol. 0.2 ml) contained 
10 mM potassium phosphate buffer, pH 7.0,2 mM 
2-mercaptoethanol, 2.5 mg of histone ml-‘, 10 mM 
MgClz, and 0.2 mM [y-32P]ATP (7.5 Ci mol-‘) with 
or without 5 PM CAMP. After addition of up to 100 
~1 of platelet fraction (1 O-l 00 pg of protein), the 
mixture was incubated for 10 min at 30°C. Incuba- 
tions were terminated by addition of 0.1 ml of 12 mM 
ATP containing bovine serum albumin (5 mg ml-‘) 
and 0.9 ml of 1% (w/v) trichloroacetic acid contain- 
ing 10 mM K2HP04. The 32P-labelled protein was iso- 
lated on glass fibre filters (Whatman F2832-24) and 
washed with 10% (w/v) trichloroacetic acid. The fd- 
ters were counted for 32P using Cerenkov radiation 
[2]. All assays were performed in triplicate. One unit 
of protein kinase activity was defined as that transfer- 
ring 1 pm01 of 32P043- from [y-32P]ATP to histone 
per min at 30°C. 
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Photoaffinity labelling of platelet fractions was 
carried out at O”C, using 8-azido- [32P]cAMP. Reaction 
mixtures (0.4 ml) contained 0.32 ml of platelet mate- 
rial, 1 mM 2-mercaptoethanol, 0.5 mM 3-isobutyl-l- 
methylxanthine and 0.09 PM or 0.5 PM 8-azido-[32Pl- 
CAMP (2-5 &i per sample). After incubation for 
20 min at O”C, the mixtures were irradiated for 10 min 
using a UVS-11 Mineralight held at a distance of 5 cm. 
In some experiments, mixtures were preincubated at 
0°C with CAMP or other agents before addition of 
8-azide [32P]cAMP. After irradiation of the mixtures, 
protein was precipitated with 0.1 ml 30% (w/v) tri- 
chloroacetic acid, dissolved in buffer containing 3% 
(w/v) SDS and 5% (v/v) 2-mercaptoethanol and anal- 
ysed by SDS-polyacrylamide gel electrophoresis 
[lo], using 11% (w/v) acrylamide in the separating el. 
The 32P-labelled polypeptides were detected by auto- 
radiography and the relative amounts of 32P in them 
were quantitated by densitometry of the autoradio- 
graphs. The apparent molecular weights of labelled 
polypeptides were determined by parallel electropho- 
resis of protein markers [2]. Protein was determined 
according to Lowry et al. [ 111. 
3. Results 
Various chelating agents and protease inhibitors 
were added to samples of platelet suspension prior to 
their sonication and the protein kinase activities of 
the platelet lysates and of supernatant and particulate 
fractions prepared from them were then determined 
(table 1). The percentages of both the CAMP-depen- 
dent and independent activities recovered in the par- 
ticulate fraction were increased 2 to 3-fold when EGTA 
or EDTA was used. This reflected statistically signifi- 
cant increases in the specific activities of these frac- 
tions. Leupeptin (0.2 mM) had similar though slightly 
weaker effects. At the same time, these agents tended 
to decrease the supernatant protein kinase activities 
(table 1). In contrast, neither aprotinin (1 trypsin in- 
hibitory unit per ml) nor benzamidine (10 mM) had 
any effect on the subcelIular distribution of protein 
kinase activities. 
Photoaffinity labelling of platelet lysates (prepared 
in the presence of 10 mM EDTA and 1 mM DFP) 
with 0.5 PM 8-azido-[32P]cAMP, followed by electro- 
phoresis of the platelet protein, always revealed two 
32P-labelled polypeptides with apparent M, values of 
55 000 and 49 000 (fig.1). Less consistently, labelled 
polypeptides with apparent M, values of 38 000 and 
52 000 were also observed. The 49 000 and 55 000 
MI polypeptides had the same electrophoretic mobil- 
ities as polypeptides that could be photoaffinity 
labelled in rabbit skeletal and bovine heart muscle 
supernatants (fig. 1) and their molecular weights cor- 
responded to those of the RI and R,, subunits of 
Table 1 
Effects of different inhibitors of proteolysis on the subcellular distribution of protein kinase activity in platelets 
Addition to 
platelet 
suspension 
No. Specific activity of 
of whole lysate 
expts (units/mg protein) 
-CAMP +cAMP 
Specific activity of 
supernatant fraction 
(units/mg protein) 
-CAMP +cAMP 
Specific activity of 
particulate fraction 
(units/mg protein) 
-CAMP +cAMP 
Percentage of 
total activity in 
particulate fraction 
-CAMP +cAMP 
None 
EGTA (5 mM) 
EDTA (5 mM) 
Leupeptin 
(0.2 mM) 
Aprotinin 
(1 unit ml-’ ) 
Benzamidine 
(10 mM) 
9 322 519 411 860 131 216 11.3 9.2 
7 236 620 224a 791 338a 582a 37.3b 23.6b 
7 288 631 320a 776 316a 558a 28.4b 22.6b 
5 241 484 272 614 268 365a 26.2a 17.3a 
4 288 550 359 156 119 175 13.1 8.4 
5 268 650 357 853 122 207 11.3 8.7 
Mean values from the no. of expts indicated are given; values significantly different from the controls with no additions are 
shown: a P < 0.05, b P < 0.01 (paired t test) 
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tion (fig.2 and 3). In four experiments in which EDTA 
was used, 61 * 4% (mean f S.E.M.) of this labelled 
polypeptide was particle-bound. These agents also in- 
creased the labelling of the 5.5 000 ill, polypeptide, 
which was found almost exclusively in the supernatant 
fraction, and largely prevented the appearance in the 
supernatant of several smaller labelled polypeptides 
(M, 45 000,4 1 000,38 000 and 36 000) presumably 
proteolytic breakdown products of the 49 000 and 
55 000 Mr species. Benzamidine and aprotinin, on the 
other hand, did not prevent loss of the 49 000 and 
55 OOOJI~, polypeptides. DFP (1 mM, not shown) had 
variable effects, depending on the batch used, which 
were independent of its ability to inhibit trypsin. When 
photoaffinity labelling was carried out with a lower 
concentration of 8-azido-[32P]~AMP (0.09 PM), label- Fig.1. Photoaffinity-labelling of platelet lysate and of bovine 
heart and rabbit skeletal muscle supernatants by X-azido- 
[32P]cAMP (0.5 p&L). EDTA (10 mM) and DFP (1 mM) were 
added to platelet suspension before sonication. After photo- 
affinity labelling, protein samples were electrophoresed as 
follows: (a) bovine heart supernatant, (b) rabbit skeletal 
muscle supernatant and (c-g) platelet lysate. Before the addi- 
tion of 8-azido-[32P]cAMP, samples of platelet lysate were 
incubated for 20 mm with (c) no addition, (d) 1 WM CAMP, 
(e) 10 &I CAMP, (f) 10 PM cyclic GMP and (g) 10 I.LM AMP. 
An autoradiograph is shown. 
CAMP-dependent protein kinases from these tissues 
[ 131. However, in bovine heart the main photoaffinity- 
labelled polypeptide had an apparent J4, 57 000 (the 
phosphorylated form of the RI, subunit [ 141) and 
did not correspond to any labelled platelet polypep- 
tide. The 49 000 M, 32P-labelled polypeptide often 
appeared as a closely spaced doublet, with equally 
labelled components. Photoaffinity label@ of both 
the 55 000 and the 49 000 bfr polypeptides was sup- 
pressed by preincubation of the platelet lysate with 
1 PM or 10 ,zM CAMP, but not by 10 PM cyclic GMP 
or 10 PM AMP, indicating tllat specific CAMP-binding 
sites were labelled (tig.1). Labelling of the 38 OOOM, 
polypeptide, which is probably a proteolytic degrada- 
tion product, and of the 52 000 il4, polypeptide were 
also suppressed by preincubation with CAMP, but 
labelling of a few minor polypeptides in the 80 OOO- 
8.5 OOOM, range was not affected. 
Photoaffinity labelling of the supernatant and par- 
ticulate fractions of lysates prepared in the presence 
and absence of various chelating agents and protease 
inhibitors showed that EGTA, EDTA and leupeptin 
markedly increased the amount of 32P-labelled poly- 
peptide withM, 49 000 found in the particulate frac- 
Fig.2. Effects of inhibitors of proteolysis on the photoaffinity 
labelling of (A) supernatant and (B) particulate fractions of 
platelet lysate by 0.5 &I 8-azidoj3’P]cAMP. Prior to their 
sonication, samples of platelet suspension were mixed with 
the following additions (final concentrations): (a) none, (b) 
S mM EGTA, (c) 5 mM EDTA, (d) 10 m,M benzamidine and 
(e) 1 trypsin inhibitory unit of aprotinin per ml. The amount 
of supernatant fraction protein elcctrophorescd was derived 
from half as many platelets as the amount of particulate frac- 
tion used. As markers for the RL and RLL regulatory subunits 
of CAMP-dependent protein kinases, rabbit skeletal muscle 
(f,l and bovine heart muscle Cg) supernatants were photoaftinity 
labelled and electrophoresed in parallel with the platelet 
samples. An autoradiograph is shown. 
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Fig.3. Effects ofinhibitors of proteolysis on the photoaffinity 
labelling of (A) supernatant and (B) particulate fractions of 
platelet lysate by 0.09 bM 8-azido-[32P]cAMP. Prior to their 
sonication, samples of platelet suspension were mixed with 
the following additions (final concentrations): (a) none, (b) 
5 mM EDTA, (c) 5 mM EGTA and (d) 0.2 mM leupeptin. 
The amounts of supernatant and particulate fraction protein 
electrophoresed were obtained from the same number of 
platelets. Bovine heart muscle supernatant was photoaftinity 
labelled and electrophoresed in (e). 
ling of the 55 OOOM, polypeptide was decreased rela- 
tive to that of the 49 000 J4, polypeptide and, as a 
result, the 52 OOOM, species wasmore readily observed 
and shown to be soluble (fig.3). 
4. Discussion 
Our results indicate that EGTA, EDTA and leu- 
peptin markedly increase both the CAMP-dependent 
protein kinase activity and the amount of photoaftin- 
ity polypeptide with M, of 49 000 found in the par- 
ticulate fraction of platelet lysates. At the same time, 
these agents increased the amount of a 55 000 M, 
photoaffinity-labelled polypeptide detected in the 
supernatant fraction; very little of the latter polypep- 
tide was found in the particulate fraction. As the pho- 
toaffinity labelling of both of these polypeptides was 
specifically inhibited by CAMP, they are likely to be 
the regulatory subunits of type I and type II CAMP- 
dependent protein kinases, which have corresponding 
molecular weights [ 131 and show similar patterns of 
photoaffinity labelling in other tissues [ 14-181. We 
infer that under conditions in which endogenous pro- 
teolysis is prevented, over half of the type I platelet 
enzyme is particle bound, whereas almost all of the 
type II enzyme is soluble. These results are consistent 
with those of Lyons [ 191. Membrane-bound type I 
CAMP-dependent protein kinase has also been observed 
in synaptic membranes [16] and in red cells [20]. 
Although only one form of the photoaffinity- 
labelled R, subunit has previously been resolved by 
SDS-polyacrylamide gel electrophoresis [15,16,18, 
191, two or more forms, which may be related to the 
doublet we often observed, can be separated by iso- 
electric focussing [ 19,211. In bovine heart and porcine 
skeletal muscle, both phosphorylated and non-phos- 
phorylated RI1 subunits are present and can be sepa- 
rated by SDS-polyacrylamide gel electrophoresis 
[ 14,181. However, electrophoresis of photolabelled 
polypeptides from platelets in parallel with those from 
bovine heart suggests that platelets do not, as claimed 
by Lyons [ 191, normally contain phosphorylated RI1 
subunits. Incubation of intact platelets with agents 
that increase CAMP leads to the endogenous phospho- 
rylation of a 50 000 M, polypeptide but this has an 
electrophoretic mobility significantly greater than 
that of the platelet Rlt subunit [3]. The 52 OOOM, 
polypeptide sometimes observed after photoaffinity 
labelling of platelets lysate or supernatant may be 
related to that recently detected in bovine brain [22] 
and could be either a proteolytic fragment or minor 
variant of the R,, subunit. 
Supernatant fractions from platelets sonicated in 
the absence of additions showed consistent patterns 
of photoaffinity-labelled fragments of the CAMP-bind- 
ing proteins. Endogenous proteolysis of the R, and 
R,, subunits has also been observed in other tissues 
[ 17,231. The appearance of these fragments under 
conditions in which loss of particulate protein kinase 
activity was observed, suggests that the enzyme was 
released by a proteolytic mechanism. This could be 
due to proteolysis of R, subunits, if they bind the 
catalytic subunits to the particulate fraction, or to 
the additional proteolysis of an anchor protein. The 
observation that EGTA prevented the release of 
CAMP-dependent protein kinase activity suggests that 
the Ca2+-activated protease, that is known to be pres- 
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ent in platelets [24], was responsible for this effect. 
In support of this view, leupeptin which unlike aproti- 
nin is a potent inhibitor of this enzyme [25], also 
reduced enzyme release. Our results demonstrate the 
importance of preventing endogenous proteolysis in 
studies on the phosphorylation of platelet membrane 
proteins and suggest hat membrane-bound type I 
enzyme may normally mediate the CAMP-dependent 
phosphorylation of the membrane polypeptides 
thought to be important in the inhibition of platelet 
function by CAMP [2,3,7]. 
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